Rasheed, Afshan Asghar <br/><br/>
Cd20 Expression and Effects on Outcome of Relapsed/<br/>Refractory Diffuse Large B Cell Lymphoma after Treatment<br/>with Rituximab  [electronic resource] 

 -  Asian Pacific journal of cancer prevention : APJCP  Feb 2018 
 - 331-335 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2476-762X 
<br/><br/><label>Standard No.: </label>10.22034/APJCP.2018.19.2.331  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antigens, CD20--metabolism<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Biomarkers, Tumor--metabolism<br/>Drug Resistance, Neoplasm<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--diagnosis<br/>Prognosis<br/>Remission Induction<br/>Retrospective Studies<br/>Rituximab--therapeutic use<br/>Survival Rate<br/>Young Adult